KIT and melanoma: We found that the ERK pathway is constitutively activated in Grey horse melanoma tumours and cells in the absence of somatic oncogenic mutations in BRAF, RAS, GNAQ, GNA11 and KIT that are associated with activation of this pathway in the majority of human melanocytic tumours.